These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29734737)

  • 1. Inhibition of v-
    Yao Y; Zhang Y; Tang N; Pedrera M; Shen Z; Nair V
    Viruses; 2018 May; 10(5):. PubMed ID: 29734737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of gga-miR-155 by reticuloendotheliosis virus T strain and its contribution to transformation.
    Yao Y; Vasoya D; Kgosana L; Smith LP; Gao Y; Wang X; Watson M; Nair V
    J Gen Virol; 2017 Apr; 98(4):810-820. PubMed ID: 28113043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
    Morrison LE; Boehmelt G; Beug H; Enrietto PJ
    Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the v-Rel dimerization interface reveals a critical role for v-Rel homodimers in transformation.
    Liss AS; Bose HR
    J Virol; 2002 May; 76(10):4928-39. PubMed ID: 11967310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
    Xu X; Gélinas C
    Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of avian lymphoid cells by reticuloendotheliosis virus.
    Moore BE; Bose HR
    Mutat Res; 1988 Jan; 195(1):79-90. PubMed ID: 2827014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
    Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
    J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells.
    Gilmore TD; Temin HM
    J Virol; 1988 Mar; 62(3):703-14. PubMed ID: 2828665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
    White DW; Pitoc GA; Gilmore TD
    Mol Cell Biol; 1996 Mar; 16(3):1169-78. PubMed ID: 8622661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
    Epinat JC; Dvorin EL; Gilmore TD
    Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
    Schatzle JD; Kralova J; Bose HR
    J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the v-rel protein with an NF-kappa B DNA binding site.
    Kabrun N; Hodgson JW; Doemer M; Mak G; Franza BR; Enrietto PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1783-7. PubMed ID: 1848011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
    Sif S; Gilmore TD
    J Virol; 1993 Dec; 67(12):7612-7. PubMed ID: 8230480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
    Hrdlicková R; Nehyba J; Bose HR
    J Virol; 1995 Jun; 69(6):3369-80. PubMed ID: 7745683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.
    Bhat GV; Temin HM
    Oncogene; 1990 May; 5(5):625-34. PubMed ID: 2189101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the oncogene of avian reticuloendotheliosis virus in Escherichia coli and identification of the transforming protein in reticuloendotheliosis virus T-transformed cells.
    Herzog NK; Bose HR
    Proc Natl Acad Sci U S A; 1986 Feb; 83(3):812-6. PubMed ID: 3003751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein.
    Nehyba J; Hrdlicková R; Bose HR
    Oncogene; 1997 Jun; 14(24):2881-97. PubMed ID: 9205096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.
    Rayet B; Fan Y; Gélinas C
    Mol Cell Biol; 2003 Mar; 23(5):1520-33. PubMed ID: 12588973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
    Gélinas C; Temin HM
    Oncogene; 1988 Oct; 3(4):349-55. PubMed ID: 2856247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.